TickerFactsScreenerDevelopers

GALECTIN THERAPEUTICS INC (GALT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$3.10M2011: -$5.68M2012: -$7.50M2017: -$15.89M2018: -$10.18M2019: -$10.85M2020: -$20.60M2021: -$24.31M2022: -$31.06M2023: -$32.97M2024: -$41.77M2025: -$23.88M-$23.88M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$23.88M+42.8%
2024-$41.77M-26.7%
2023-$32.97M-6.1%
2022-$31.06M-27.8%
2021-$24.31M-18.0%
2020-$20.60M-89.9%
2019-$10.85M-6.6%
2018-$10.18M+35.9%
2017-$15.89M—
2012-$7.50M-32.1%
2011-$5.68M-83.0%
2010-$3.10M—